UBE2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.747400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.831400E-01
Normal-vs-Stage2
9.602600E-01
Normal-vs-Stage3
1.640590E-01
Normal-vs-Stage4
4.374600E-01
Stage1-vs-Stage2
9.019200E-01
Stage1-vs-Stage3
6.226400E-02
Stage1-vs-Stage4
2.808400E-01
Stage2-vs-Stage3
2.016600E-01
Stage2-vs-Stage4
4.432000E-01
Stage3-vs-Stage4
5.384200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.579800E-01
Normal-vs-AfricanAmerican
6.510000E-01
Normal-vs-Asian
9.300800E-01
Caucasian-vs-AfricanAmerican
6.614200E-01
Caucasian-vs-Asian
9.076800E-01
AfricanAmerican-vs-Asian
7.990000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.640800E-01
Normal-vs-Female
8.904400E-01
Male-vs-Female
5.073400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.830400E-01
Normal-vs-Age(41-60Yrs)
5.431600E-01
Normal-vs-Age(61-80Yrs)
7.704000E-01
Normal-vs-Age(81-100Yrs)
2.249000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.559600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.581800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.455000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.100500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.806000E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.259800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.492800E-01
Normal-vs-Daily Drinker
9.884600E-01
Normal-vs-Weekly Drinker
4.051600E-01
Normal-vs-Occasional Drinker
6.309000E-01
Normal-vs-Social Drinker
7.432000E-01
Non Drinker-vs-Daily Drinker
8.714600E-01
Non Drinker-vs-Weekly Drinker
2.062200E-01
Non Drinker-vs-Occasional Drinker
2.982600E-01
Non Drinker-vs-Social Drinker
7.125200E-01
Daily Drinker-vs-Weekly Drinker
1.886830E-01
Daily Drinker-vs-Occasional Drinker
4.139600E-01
Daily Drinker-vs-Social Drinker
6.208600E-01
Weekly Drinker-vs-Occasional Drinker
3.387600E-02
Weekly Drinker-vs-Social Drinker
3.282600E-01
Occasional Drinker-vs-Social Drinker
1.671790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.545910E-02
Normal-vs-Grade 2
3.226600E-04
Normal-vs-Grade 3
2.464200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.283560E-01
Grade 1-vs-Grade 3
2.740400E-01
Grade 1-vs-Grade 4
1.545910E-02
Grade 2-vs-Grade 3
8.455000E-01
Grade 2-vs-Grade 4
3.226600E-04
Grade 3-vs-Grade 4
2.464200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.890200E-01
Normal-vs-NonDiabetic
9.779600E-01
Diabetic-vs-NonDiabetic
3.849400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.321000E-01
Normal-vs-NoPancreatitis
9.883400E-01
Pancreatitis-vs-NoPancreatitis
9.257600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.680000E-01
Normal-vs-N1
9.240000E-01
N0-vs-N1
3.970000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.773600E-01
Normal-vs-TP53-NonMutant
6.986000E-01
TP53-Mutant-vs-TP53-NonMutant
2.694200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
